This study aimed to identify the optimal strategy to prevent postoperative disease recurrence. METHODS: In this randomised trial, consecutive. Natural history studies in Crohn's disease (CD) reveal that one-half of patients require surgery within 10 years after diagnosis (Am J Gastroenterol. Preliminary data from the POCER study was presented in abstract form demonstrated that at 6 mo 94% of high-risk patients treated with NATURAL HISTORY OF · MEDICAL THERAPIES TO · USING ENDOSCOPIC.
Pocer studie Video
Crazy Sick Hero Call by Davidi Kitai! De Cruz P 1 , Kamm MA 1 , Hamilton AL 1 , Ritchie KJ 2 , Krejany EO 1 , Gorelik A 3 , Liew D 3 , Prideaux L 1 , Lawrance IC 4 , Andrews JM 5 , Bampton PA 6 , Jakobovits S 7 , Florin TH 8 , Gibson PR 7 , Debinski H 9 , Gearry RB 10 , Macrae FA 11 , Leong RW 12 , Kronborg I 13 , Radford-Smith G 14 , Selby W 15 , Johnston MJ 2 , Woods R 2 , Elliott PR 2 , Bell SJ 1 , Brown SJ 2 , Connell WR 2 , Desmond PV 2. Thus at 18 mo, there was no difference between endoscopic recurrence in patients who received adalimumab immediately post operatively and those who had tailored therapy based on 6 mo endoscopy[ 60 ]. Recurrence Crohn Disease Disease Attributes Pathologic Processes Inflammatory Bowel Diseases. Thiopurines Azathioprine and 6-mercaptopurine are efficacious in maintenance of CD and have been extensively studied in the post-operative setting. Viazis N, Giakoumis M, Koukouratos T, Anastasiou J, Katopodi K, Kechagias G, Anastasopoulos E, Saprikis E, Chanias M, Tribonias G, et al. Patients at high risk are those